glp 1 for 3 months GLP-1/GIP Results After 1, 3, and 6 Real Results. Real People. Just
Description
Adults with obesity and autoimmune disease taking GLP-1 medication experience fewer cardiac events and have a lower risk of death, according to new findings.
GLP-1, semaglutide & tirzepatide programs tailored to your biology
2023 Apr 6;18(4):e0281150
Access 365 days a year
However, clinical evidence remains limited, with most studies confined to preclinical models
Almost one-third (31%) of all patients dispensed the drugs in 2023 had no recorded diagnosis of either diabetes or obesity, compared to 8% in 2019
